Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice

Low hemagglutinin antigen dose influenza vaccines adjuvanted with AS03 alter the long-term immune responses in BALB/c mice

We investigated the long-term immune profiles of dose-sparing, AS03-adjuvanted vaccines compared to a traditional high-dose, unadjuvated influenza vaccine formulation. BALB/c mice received 2 IM injections of influenza A/Uruguay/716/2007 (H3N2) split vaccine antigen: high-dose (HD) (3 µg hemagglutini...

Full description

Bibliographic Details
Main Authors:	Karen K. Yam, Angela Brewer, Virginie Bleau, Édith Beaulieu, Corey P. Mallett, Brian J. Ward
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2017-03-01
Series:	Human Vaccines & Immunotherapeutics
Subjects:	adjuvant antibody-secreting cells as03 cytokine chemokine dose-sparing hemagglutination inhibition influenza long-term immune response microneutralization vaccine
Online Access:	http://dx.doi.org/10.1080/21645515.2016.1241360

Similar Items

AS03-adjuvanted, very-low-dose influenza vaccines induce distinctive immune responses compared to unadjuvanted high-dose vaccines in BALB/c mice
by: Karen K Yam, et al.
Published: (2015-04-01)

AddaVax-Adjuvanted H5N8 Inactivated Vaccine Induces Robust Humoral Immune Response against Different Clades of H5 Viruses
by: Feixia Gao, et al.
Published: (2022-10-01)

Influence of sample collection tube method, anticoagulant-containing plasma versus serum, on influenza virus hemagglutination inhibition titer and microneutralization titer serological assays
by: Brian J. Morrison, et al.
Published: (2018-08-01)

The Comparison of Sensitivity and Specificity of ELISA-based Microneutralization Test with Hemagglutination Inhibition Test to Evaluate Neutralizing Antibody against Influenza Virus (H1N1)
by: Ahmad TAVAKOLI, et al.
Published: (2017-11-01)

PROBLEMS OF ISOLATION, IDENTIFICATION AND ANTIGENIC CHARACTERIZATION OF RECENT HUMAN A(H3N2) INFLUENZA VIRUSES
by: P. A. Petrova, et al.
Published: (2018-08-01)

Hemagglutinins of haemophilus paragallinarum Serotype 1 organisms /
by: 271463 Akira Sawata, et al.

Purification of hemagglutinin from haemophilus paragallinarum using monoclonal antibody /
by: Masami Takagi

Difference of chicken red blood cells in susceptibility to haemophilus paragallinarum hemagglutinin /
by: 272861 Yoshikazu Iritani, et al.

Production and properties of Hemagglutinin of Haemophilus gallinarum /
by: 384917 Y. Iritani, et al.

DETERMINATION OF RUBELLA HEMAGGLUTINATION INHIBITION ANTIBODY TITER IN 18 TO 25 YEARS OLD WOMEN IN TEHRAN
by: M.Nafar Abady, et al.
Published: (1980-06-01)

Features 2016–2018 current human influenza A(H3N2) viruses circulating in Russia
by: P. A. Petrova, et al.
Published: (2020-02-01)

Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses
by: Amanda L. Skarlupka, et al.
Published: (2019-09-01)

Isolation of Influenza Virus and Isolation of Influenza Virus and Typing in 1993
by: Masoud Saboori, et al.
Published: (1995-09-01)

Microneutralization reaction compared to hemagglutination inhibition assay to evaluate immunogenicity of influenza vaccines and influenza diagnostics
by: V. Z. Krivitskaya, et al.
Published: (2020-02-01)

Antigen-Sparing and Enhanced Efficacy of Multivalent Vaccines Adjuvanted with Immunopotentiators in Chickens
by: Peipei Wu, et al.
Published: (2017-05-01)

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older
by: Hideyuki Ikematsu, et al.
Published: (2012-08-01)

Intradermal Immunization of SARS-CoV-2 Original Strain Trimeric Spike Protein Associated to CpG and AddaS03 Adjuvants, but Not MPL, Provide Strong Humoral and Cellular Response in Mice
by: Luan Firmino-Cruz, et al.
Published: (2022-08-01)

Physico-chemical characterization of a natural agglutinin from the hemolymph of a millipede Thyropygus descriptus
by: SrMR Basil-Rose, et al.
Published: (2014-11-01)

Chemokines as Cancer Vaccine Adjuvants
by: Agne Petrosiute, et al.
Published: (2013-10-01)

Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
by: Adrian Egli, et al.
Published: (2014-05-01)

Impact of age and pre-existing immunity on the induction of human antibody responses against influenza B viruses
by: Michael A. Carlock, et al.
Published: (2019-09-01)

Comparison of DIA with hemagglutination inhibition (HI) and enzyme immunoassay (EIA) in diagnosis of Measles
by: Y Yahya Pour, et al.
Published: (2001-04-01)

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study
by: Joanna Waldock, et al.
Published: (2021-08-01)

Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyResearch in context
by: Guy de Bruyn, et al.
Published: (2023-08-01)

Analysis of the dose-sparing effect of adjuvanted Sabin-inactivated poliovirus vaccine (sIPV)
by: Zhuofan Li, et al.
Published: (2018-08-01)

Assessment of seroprevalence against poliovirus among Italian adolescents and adults
by: Silvia Lupi, et al.
Published: (2019-03-01)

T Cell Transcriptional Signatures of Influenza A/H3N2 Antibody Response to High Dose Influenza and Adjuvanted Influenza Vaccine in Older Adults
by: Iana H. Haralambieva, et al.
Published: (2022-12-01)

EVALUATING THE EFFICACY OF A POLYVALENT INFECTIOUS CORYZA VACCINE AGAINST EMERGING AVIBACTERIUM PARAGALLINARUM SEROTYPES IN EGYPT
by: Mahmoud Assad, et al.
Published: (2021-12-01)

The prevalence of secretor status and co-expression of lewis antigen in voluntary blood donors
by: R Raj Bharath
Published: (2016-08-01)

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN
by: S. Saidi
Published: (1974-08-01)

VIRAL ANTIBODIES IN PRESCHOOL CHILDREN
by: S. Saidi
Published: (1974-06-01)

Interlaboratory Reproducibility of Standardized Hemagglutination Inhibition Assays
by: David C. Bibby, et al.
Published: (2022-02-01)

Advances in Adjuvanted Influenza Vaccines
by: Shintaro Shichinohe, et al.
Published: (2023-08-01)

An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study
by: Joanna Waldock, et al.
Published: (2023-02-01)

Comprehensive Cross-Sectional Evaluation of Human Sandfly-Borne Phlebovirus Exposure in an Endemic Region
by: Ceylan Polat, et al.
Published: (2023-09-01)

Proteolytic Processing, Maturation, and Unique Synteny of the Streptomyces Hemagglutinin SHA
by: Yoko Fujita-Yamaguchi, et al.
Published: (2021-10-01)

Month of Influenza Virus Vaccination Influences Antibody Responses in Children and Adults
by: Rhiannon R. Penkert, et al.
Published: (2021-01-01)

Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test
by: Seung Youn Kim, et al.
Published: (2012-12-01)

Detection of H1 Swine Influenza A Virus Antibodies in Human Serum Samples by Age Group
by: Elien Vandoorn, et al.
Published: (2020-09-01)

An antimicrobial activity of oil extracted from Saara hardwickii
by: M. Arshad, et al.
Published: (2022-02-01)